Add to a list

Inactive Instrument

LOTUS PHARM Share Price OTC Bulletin Board

LTUS

US5457151042

Pharmaceuticals

OTC Markets Traded

End-of-day quote OTC Bulletin Board
- ^USD	-

31/23/31	Amarin, Lotus Pharmaceuticals Agree to Exclusive Vazkepa Distribution Deal in 10 Asian Countries	MT
26/21/26	Thai oil firm PTT expands pharma business with $475 million Alvogen deal	RE

Lotus Pharmaceuticals Inc is a company mainly engaged in development, manufacture, and sales of pharmaceuticals. The Company produces crude medicine and drugs in forms of tablets, capsules, granules, eye-drops, and freeze-dried powder injection. The Company's drug development is focused on the treatment of cerebro-cardiovascular disease, asthma, and diabetes. The Company operated in two business segment Wholesales segment and Retail segment. The Company's products include Maixin-valsartan capsules for the treatment of hypertension, Muxineye drops for the treatment of glaucoma and Yipubishan-octreotide Acetate Injection solution for the treatment of gastric ulcers. The Company mainly conducts its businesses in the domestic market and overseas markets.

Employees

Sector

Pharmaceuticals

More about the company

As early as today, start finding the best investment opportunities!

Market Cap	97.36L 86.95L 80.89L 73.57L 1.39Cr 94Cr 1.4Cr 9.74Cr 3.81Cr 48Cr 3.66Cr 3.58Cr 154.16Cr	P/E 2009	3.88x	P/E 2010	4.84x
Enterprise Value	1.44Cr 1.28Cr 1.19Cr 1.09Cr 2.05Cr 139.19Cr 2.06Cr 14Cr 5.63Cr 71Cr 5.4Cr 5.28Cr 227.73Cr	EV / Sales 2009	1.02x	EV / Sales 2010	0.95x
Free-Float	99%	Yield 2009 *	-	Yield 2010	-

31/23/31	Amarin, Lotus Pharmaceuticals Agree to Exclusive Vazkepa Distribution Deal in 10 Asian Countries	MT
26/21/26	Thai oil firm PTT expands pharma business with $475 million Alvogen deal	RE
28/21/28	Lotus Pharmaceuticals : Temasek-backed Vertex expects at least $400 million in new S.E.Asia/India fund	RE
16/12/16	Lotus Pharmaceuticals, Inc. has Changed its Ticker to LTUS from LTUSE	CI
19/12/19	Lotus Pharmaceuticals, Inc. has Changed its Ticker to LTUS.E from LTUS	CI

30/12	Lotus Pharmaceutical Supports Street Medicine Program to Expand Access to Care for Those Most in Need	AQ
06/25/06	Lotus Enters License and Supply Agreement with Adalvo for Semaglutide injection	AQ
12/25/12	Lotus Pharmaceutical Achieves New First-Half Record in Revenue for 2025, While Q2 Impacted by FX and Timing of Lenalidomide Sales	AQ
21/25/21	Lotus announces FDA acceptance of Potential First-to-File ANDA Submission for Voclosporin soft gelatin capsules, a generic equivalent to Lupkynis	AQ
08/24/08	Lotus Achieves Second-Highest Quarterly Performance in Company History with 3Q24 Financial Results	AQ

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELI LILLY AND COMPANY	+0.83%	+3.19%	+41.49%	+103.56%	1,05100Cr
JOHNSON & JOHNSON	+1.93%	+2.11%	+37.08%	+65.09%	63TCr
ABBVIE INC.	+1.49%	+5.19%	+19.94%	+85.69%	49TCr
MERCK & CO., INC.	+2.26%	+0.90%	+69.32%	+40.53%	36TCr
ROCHE HOLDING AG	+1.45%	+3.50%	+23.29%	+41.62%	34TCr
NOVARTIS AG	+1.17%	+2.37%	+13.47%	+33.64%	27TCr
ASTRAZENECA PLC	+0.89%	+1.08%	-6.13%	+9.29%	25TCr
AMGEN INC.	+1.82%	+2.94%	+42.99%	+52.95%	22TCr
GILEAD SCIENCES, INC.	+2.77%	+4.44%	+29.01%	+98.99%	19TCr
Average	+1.62%	+2.53%	+30.05%	+59.04%	42.26TCr
Weighted average by Cap.	+1.47%	+2.44%	+33.36%	+69.01%

	2009	2010
Net sales	5.78Cr 5.16Cr 4.8Cr 4.37Cr 8.25Cr 559.63Cr 8.29Cr 58Cr 23Cr 285.32Cr 22Cr 21Cr 915.6Cr	7.27Cr 6.49Cr 6.04Cr 5.49Cr 10Cr 703.56Cr 10Cr 73Cr 28Cr 358.7Cr 27Cr 27Cr 1.15TCr
Net income	1.64Cr 1.47Cr 1.37Cr 1.24Cr 2.34Cr 159.03Cr 2.35Cr 16Cr 6.44Cr 81Cr 6.17Cr 6.04Cr 260.19Cr	1.44Cr 1.29Cr 1.2Cr 1.09Cr 2.06Cr 139.61Cr 2.07Cr 14Cr 5.65Cr 71Cr 5.42Cr 5.3Cr 228.41Cr
Net Debt	5.29 4.73 4.4 4 7.55 512.34 7.59 52.93 20.74 261.21 19.88 19.44 838.23	4.65 4.15 3.86 3.51 6.63 449.71 6.66 46.46 18.21 229.28 17.45 17.07 735.77

LOTUS PHARM Share Price OTC Bulletin Board

Stocks

LTUS

US5457151042

Pharmaceuticals

Valuation: LOTUS PHARM

Latest news: LOTUS PHARM

Press Releases: LOTUS PHARM

Managers and Directors: LOTUS PHARM

Generic Pharmaceuticals

Financials

Company Profile